Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;60(12):2899-2908.
doi: 10.1080/10428194.2019.1617858. Epub 2019 Jun 19.

The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population

Affiliations

The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population

Charlie Zhong et al. Leuk Lymphoma. 2019 Dec.

Abstract

Several studies have implicated HLA in non-Hodgkin lymphoma (NHL) subtype etiology. However, NHL patients indicated for stem cell transplants are underrepresented in these reports. We therefore evaluated the association between HLA and NHL subtypes among a transplant-indicated population. One thousand three hundred and sixty-six NHL patients HLA-typed and indicated for transplant at the City of Hope National Medical Center (Duarte, CA) were compared to 10,271 prospective donors. Odds ratios and 95% confidence intervals were calculated for HLA haplotype and alleles, adjusted for sex and age. The HLA-A*0201∼C*0602∼B*1302∼DRB1*0701∼DQB1*0201 haplotype was significantly associated with follicular lymphoma (FL) risk among Caucasians. Several haplotypes were associated with diffuse large B-cell lymphoma (DLBCL) risk among Caucasians, including the previously implicated DLBCL risk loci, HLA-B*0801. The HLA-A*0101 allele was also observed to be associated with mantle cell lymphoma (MCL) risk. Our results support the association between previously reported susceptibility loci and FL and suggest potentially new DLBCL and MCL risk loci.

Keywords: Epidemiology; HLA; bone marrow transplant; lymphoma.

PubMed Disclaimer

Conflict of interest statement

Competing Interests

The authors declare that they have no competing financial interests.

Similar articles

Cited by

References

    1. Johnson PCD, McAulay KA, Montgomery D, Lake A, Shield L, Gallagher A, et al. Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis. International Journal of Cancer 2015; 137(5): 1066–1075. - PMC - PubMed
    1. McAulay KA, Jarrett RF. Human leukocyte antigens and genetic susceptibility to lymphoma. Tissue Antigens 2015; 86(2): 98–113. - PubMed
    1. Wang SS, Lu Y, Rothman N, Abdou AM, Cerhan JR, De Roos A, et al. Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1. PLoS ONE 2011; 6(11): e26949. - PMC - PubMed
    1. Riemersma SA, Jordanova ES, Haasnoot GW, Drabbels J, Schuuring E, Schreuder GMT, et al. The Relationship Between HLA Class II Polymorphisms and Somatic Deletions in Testicular B Cell Lymphomas of Dutch Patients. Human Immunology 2006. 4//; 67(4–5): 303–310. - PubMed
    1. Abdou AM, Gao X, Cozen W, Cerhan JR, Rothman N, Martin MP, et al. Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia 2010. May; 24(5): 1055–1058. - PMC - PubMed

Publication types